Metabolism of Some “Second”– and “Fourth”–Generation Antidepressants: Iprindole, Viloxazine, Bupropion, Mianserin, Maprotiline, Trazodone, Nefazodone, and Venlafaxine
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 19 (4) , 427-442
- https://doi.org/10.1023/a:1006953923305
Abstract
1. This review summarizes the major known aspects of the metabolism of second-generation (iprindole, viloxazine, bupropion, mianserin, maprotiline, and trazodone) and fourth-generation (nefazodone...Keywords
This publication has 98 references indexed in Scilit:
- Safety, Tolerance, and Preliminary Pharmacokinetics of Nefazodone After Administration of Single and Multiple Oral Doses to Healthy Adult Male Volunteers: A Double-Blind, Phase I StudyThe Journal of Clinical Pharmacology, 1995
- Pharmacokinetic Optimisation of Therapy with Newer AntidepressantsClinical Pharmacokinetics, 1994
- TrazodoneDrugs & Aging, 1994
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Pharmacokinetic Interactions Between Theophylline and Other Medication (Part I)1Clinical Pharmacokinetics, 1991
- Fluoxetine Drug-Drug InteractionsJournal of Clinical Psychopharmacology, 1990
- Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studiesGeneral Pharmacology: The Vascular System, 1989
- Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- MianserinDrugs, 1978